skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Allogeneic GM-CSF-Based Myeloma Cell Vaccine (Code C90540)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Allogeneic GM-CSF-Based Myeloma Cell Vaccine

Definition: An allogeneic tumor cell vaccine containing myeloma cancer cells transfected with the granulocyte macrophage-colony-stimulating factor (GM-CSF) gene with potential antineoplastic activity. Upon vaccination, allogeneic GM-CSF-based myeloma cellular vaccine secretes GM-CSF, which may potentiate a tumor-specific cytotoxic T-lymphocyte (CTL) response against myeloma cancer cell-associated antigens.

Display Name: Allogeneic GM-CSF-Based Myeloma Cell Vaccine

Label: Allogeneic GM-CSF-Based Myeloma Cell Vaccine

NCI Thesaurus Code: C90540 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL416221  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Allogeneic GM-CSF-Based Myeloma Cell Vaccine
Allogeneic Granulocyte Macrophage Colony-Stimulating Factor-Based Myeloma Cellular Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 664345
PDQ Open Trial Search ID 664345 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C90540
Contributing_Source CTRP
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom